{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:14:39Z","timestamp":1784308479924,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.ejca.2015.08.028","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T06:00:33Z","timestamp":1447826433000},"page":"2725-2731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["A phase II trial of low-dose estradiol in postmenopausal women with advanced breast cancer and acquired resistance to aromatase inhibition"],"prefix":"10.1016","volume":"51","clinical-trial-number":[{"clinical-trial-number":"2004-000595-14","registry":"10.18810\/euctr"}],"author":[{"given":"G.","family":"Zucchini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.C.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Wardley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Seif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.D.","family":"Ryder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Blowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2015.08.028_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/bmj.2.4368.393","article-title":"Influence of synthetic oestrogens upon advanced malignant disease","volume":"2","author":"Haddow","year":"1944","journal-title":"BMJ"},{"key":"10.1016\/j.ejca.2015.08.028_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/bjc.1971.33","article-title":"A new anti-oestrogenic agent in late breast cancer. An early clinical appraisal of ICI46474","volume":"25","author":"Cole","year":"1971","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2015.08.028_bib3","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1001\/jama.1977.03270460065023","article-title":"Diethylstilbestrol: recommended dosages for different categories of breast cancer patients. Report of the Cooperative Breast Cacner Group","volume":"237","author":"Carter","year":"1977","journal-title":"JAMA"},{"key":"10.1016\/j.ejca.2015.08.028_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM198101013040104","article-title":"Randomized clinical trial of diethylstilbestrol versus tamoxifen in postmenopausal women with advanced breast cancer","volume":"304","author":"Ingle","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2015.08.028_bib5","first-page":"1199","article-title":"Randomized comparison of tamoxifen versus diethylstilbestrol in estrogen receptor-positive or -unknown metastatic breast cancer: a Southeastern Cancer Study Group trial","volume":"70","author":"Gockerman","year":"1986","journal-title":"Cancer Treat Rep"},{"issue":"Suppl(1)","key":"10.1016\/j.ejca.2015.08.028_bib6","first-page":"83","article-title":"The tamoxifen trial \u2013 a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer \u2013 a double-blind comparison with stilboestrol in postmenopausal women with advanced breast cancer","author":"Stewart","year":"1980","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2015.08.028_bib7","first-page":"179","article-title":"Tamoxifen versus ethinyl estradiol in the treatment of postmenopausal women with advanced breast cancer","volume":"65","author":"Beex","year":"1981","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.ejca.2015.08.028_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/00000421-198504000-00004","article-title":"Randomized trial of estrogen vs. tamoxifen therapy for advanced breast cancer","volume":"8","author":"Matelski","year":"1985","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejca.2015.08.028_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1010619225209","article-title":"High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy","volume":"67","author":"Lonning","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2015.08.028_bib10","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/bjc.2013.520","article-title":"Ethinylestradiol is beneficial for postmenopausal patients with heavily pre-treated metastatic breast cancer after prior aromatase inhibitor treatment: a prospective study","volume":"109","author":"Iwase","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2015.08.028_bib11","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/003591575004301128","article-title":"Hormone therapy in relation to radiotherapy in the treatment of advanced carcinoma of the breast","volume":"43","author":"Stoll","year":"1950","journal-title":"Proceedings of the Royal Society of Medicine"},{"key":"10.1016\/j.ejca.2015.08.028_bib12","first-page":"2918","article-title":"Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells","volume":"80","author":"Masamura","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejca.2015.08.028_bib13","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1210\/endo.139.10.6229","article-title":"Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells","volume":"139","author":"Jeng","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejca.2015.08.028_bib14","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1093\/jnci\/93.22.1714","article-title":"Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17\u00df-estradiol","volume":"93","author":"Song","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2015.08.028_bib15","doi-asserted-by":"crossref","first-page":"18879","DOI":"10.1073\/pnas.1115188108","article-title":"Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time","volume":"208","author":"Ariazi","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2015.08.028_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003370.pub3","article-title":"Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women","author":"Gibson","year":"2009","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.ejca.2015.08.028_bib17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/A:1006263818115","article-title":"Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B","volume":"55","author":"Fallowfield","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejca.2015.08.028_bib18","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/jama.2009.1204","article-title":"Lower-dose vs high-dose oral estradiol therapy of hormone receptorpositive, aromatase inhibitor-resistant advanced breast cancer: a phase II randomized study","volume":"302","author":"Ellis","year":"2009","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ejca.2015.08.028_bib19","first-page":"77","article-title":"Pharmacokinetics of oral 17 beta-estradiol","volume":"37","author":"Lobo","year":"1992","journal-title":"Reprod Med"},{"issue":"3","key":"10.1016\/j.ejca.2015.08.028_bib20","first-page":"1124","article-title":"Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells","volume":"46","author":"Reiner","year":"1986","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.ejca.2015.08.028_bib21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5414\/CP201989","article-title":"Pharmacokinetics and safety profiles of novel diethylstilbestrol orally dissolving film in comparison with diethylstilbestrol capsules in healthy Chinese male subjects","volume":"52","author":"Zhang","year":"2014","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.ejca.2015.08.028_bib22","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1200\/JCO.2008.18.6213","article-title":"Endocrine effects of adjuvant letrozole compared with tamoxifen in hormone-responsive postmenopausal patients with early breast cancer: the HOBOE trial","volume":"27","author":"Rossi","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2015.08.028_bib23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1530\/eje.0.1420144","article-title":"Effect of aging on serum gonadotropin levels in healthy subjects and patients with nonfunctioning pituitary adenomas","volume":"142","author":"Vaninetti","year":"2000","journal-title":"European Journal of Endocrinology"},{"key":"10.1016\/j.ejca.2015.08.028_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1477-7819-9-101","article-title":"Clinical relevance of \u201cwithdrawal therapy\u201d as a form of hormonal manipulation for breast cancer","volume":"9","author":"Agrawal","year":"2011","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejca.2015.08.028_bib25","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1200\/JCO.2005.03.4108","article-title":"Aromatase inhibitor withdrawal response in metastatic breast cancer","volume":"24","author":"Cigler","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2015.08.028_bib26","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/oxfordjournals.annonc.a058286","article-title":"Response after withdrawal of tamoxifen and progestogens in advanced breast cancer","volume":"3","author":"Howell","year":"1992","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2015.08.028_bib27","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(02)12001-0","article-title":"Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial","volume":"360","author":"Cherry","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2015.08.028_bib28","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/1471-0528.12598","article-title":"Long-term safety of unopposed estrogen used by women surviving myocardial infarction: 14-year follow-up of the ESPRIT randomised controlled trial","volume":"121","author":"Cherry","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/j.ejca.2015.08.028_bib29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1158\/1535-7163.MCT-09-0696","article-title":"Sensitivity to the aromatase inhibitor letrozole is prolonged after a \u201cbreak\u201d in treatment","volume":"9","author":"Sabnis","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ejca.2015.08.028_bib30","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1016\/j.ejca.2006.08.020","article-title":"Continuous versus intermittent tamoxifen versus intermittent\/alternated tamoxifen and medroxyprogesterone acetate as first line endocrine treatment in advanced breast cancer: an EORTC phase III study (10863)","volume":"42","author":"Beex","year":"2006","journal-title":"Eur J Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491500845X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095980491500845X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T16:59:48Z","timestamp":1567357188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095980491500845X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":30,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S095980491500845X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2015.08.028","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase II trial of low-dose estradiol in postmenopausal women with advanced breast cancer and acquired resistance to aromatase inhibition","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2015.08.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}